ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ

Corrigendum to: ‘ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European …

[1]  J. Kingma,et al.  Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. , 1989, The American journal of cardiology.

[2]  S. Hohnloser,et al.  Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study. , 2003, European heart journal.

[3]  S. Lansman,et al.  Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. , 1999, Journal of the American College of Cardiology.

[4]  E. Lonn,et al.  Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. , 2005, American heart journal.

[5]  W. J. Hamilton,et al.  Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.

[6]  O. Benavente,et al.  Increased Risk of Intracranial Hemorrhage when Aspirin Is Combined with Warfarin: A Meta-Analysis and Hypothesis , 1999, Cerebrovascular Diseases.

[7]  R. Cebul,et al.  Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials. , 1995, American heart journal.

[8]  T Fahey,et al.  The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. , 2000, BMJ : British Medical Journal.

[9]  P. Alboni,et al.  Outpatient treatment of recent-onset atrial fibrillation with the “pill-in-the-pocket” approach , 2005 .

[10]  Claus Schmitt,et al.  Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial Fibrillation: A Randomized Comparison Between 2 Current Ablation Strategies , 2005, Circulation.

[11]  M. Allessie,et al.  Verapamil reduces tachycardia-induced electrical remodeling of the atria. , 1997, Circulation.

[12]  A. Madrid,et al.  Comparison of flecainide and procainamide in cardioversion of atrial fibrillation. , 1993, European heart journal.

[13]  D. Evans,et al.  Long-term results of DC reversion of atrial fibrillation. , 1968, British heart journal.

[14]  S. Lévy,et al.  Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. , 1997, The American journal of cardiology.

[15]  D. Levy,et al.  Obesity and the risk of new-onset atrial fibrillation. , 2004, JAMA.

[16]  P. Koudstaal,et al.  Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial , 2004, Stroke.

[17]  R. Kerber,et al.  Elective cardioversion: influence of paddle-electrode location and size on success rates and energy requirements. , 1981, The New England journal of medicine.

[18]  A. Wing,et al.  Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate. , 1970, British heart journal.

[19]  H. Crijns,et al.  Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. , 1988, The American journal of cardiology.

[20]  J L Cox,et al.  Hazards of postoperative atrial arrhythmias. , 1994, The Annals of thoracic surgery.

[21]  B. Lown,et al.  "Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients. , 1963, The New England journal of medicine.

[22]  Marlene R. Miller,et al.  The evidence regarding the drugs used for ventricular rate control. , 2000, The Journal of family practice.

[23]  G. Ewy.  Optimal technique for electrical cardioversion of atrial fibrillation. , 1992, Circulation.

[24]  T. Guarnieri,et al.  Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. , 1999, Journal of the American College of Cardiology.

[25]  R. Hauer,et al.  Identification of the substrate of atrial vulnerability in patients with idiopathic atrial fibrillation. , 2000, Circulation.

[26]  A. Goldberger,et al.  Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success. , 1982, American heart journal.

[27]  Y. Tseng,et al.  Clinical implications and factors related to left atrial spontaneous echo contrast in chronic nonvalvular atrial fibrillation. , 1994, Cardiology.

[28]  E. Vitolo,et al.  Amiodarone versus quinidine in the prophylaxis of atrial fibrillation. , 1981, Acta cardiologica.

[29]  J. Rawles,et al.  What is meant by a "controlled" ventricular rate in atrial fibrillation? , 1990, British heart journal.

[30]  B. Lüderitz,et al.  Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial. , 2004, European heart journal.

[31]  D. Singer,et al.  An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. , 1996, The New England journal of medicine.

[32]  S. Hohnloser,et al.  Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up. , 1992, Journal of the American College of Cardiology.

[33]  E. Prystowsky,et al.  Effect of continuous vagal enhancement on concealed conduction and refractoriness within the atrioventricular node. , 1996, The American journal of cardiology.

[34]  Claus Schmitt,et al.  Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation. , 2002, The American journal of cardiology.

[35]  A. Go,et al.  Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. , 2004, Journal of the American College of Cardiology.

[36]  J. Halperin,et al.  Atrial fibrillation and stroke : concepts and controversies. , 2001, Stroke.

[37]  A. Kalogeropoulos,et al.  Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter. , 2004, Journal of the American College of Cardiology.

[38]  I C van Gelder,et al.  UvA-DARE ( Digital Academic Repository ) Efficacy , safety , and determinants of conversion of atrial fibrillation and flutter with oral amiodarone , 1997 .

[39]  J. Debatin,et al.  Detection and characterization of intracardiac thrombi on MR imaging. , 2002, AJR. American journal of roentgenology.

[40]  F. London,et al.  Atrial flutter: 1 to 1 conduction during treatment with quinidine and digitalis. , 1954, American heart journal.

[41]  R. D. Murray,et al.  Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation. , 2004, The American journal of cardiology.

[42]  Arterial embolism in thyrotoxicosis with atrial fibrillation. , 1981, Archives of internal medicine.

[43]  I. V. Van Gelder,et al.  Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter. , 1991, American heart journal.

[44]  H. Crijns,et al.  Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. , 1996, Archives of internal medicine.

[45]  N. Peters,et al.  Atrial fibrillation: strategies to control, combat, and cure , 2002, The Lancet.

[46]  Otto Kamp,et al.  Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. , 2004, Journal of the American College of Cardiology.

[47]  R. Schmieder,et al.  Reversal of Left Ventricular Hypertrophy in Essential Hypertension: A Meta-analysis of Randomized Double-blind Studies , 1996 .

[48]  T. Takano,et al.  Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: endocrinologic silence. , 1991, Journal of the American College of Cardiology.

[49]  G. Koren,et al.  Pregnancy outcome after gestational exposure to amiodarone in Canada. , 1995, American journal of obstetrics and gynecology.

[50]  S. Benedetto.  Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm. , 1997 .

[51]  M. Ezekowitz,et al.  Alternate-day dosing of aspirin in atrial fibrillation: A critical evaluation. , 1999, American heart journal.

[52]  L. Horowitz,et al.  Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. , 1985, Journal of the American College of Cardiology.

[53]  M. di Mauro,et al.  VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study). , 2003, European heart journal.

[54]  N. Kerin,et al.  The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation. , 1996, Archives of internal medicine.

[55]  S. Saksena,et al.  Internal Atrial Defibrillation: Effect on Sinus and Atrioventricular Nodal Function and Implanted Cardiac Pacemakers , 1997, Pacing and clinical electrophysiology : PACE.

[56]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.

[57]  R. Prescott,et al.  CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION , 1982, The Lancet.

[58]  R. Falk,et al.  Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. , 1997, Journal of the American College of Cardiology.

[59]  M. Chung,et al.  Comparison of the rectilinear biphasic waveform with the monophasic damped sine waveform for external cardioversion of atrial fibrillation and flutter. , 2004, The American journal of cardiology.

[60]  S. Nattel,et al.  Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. , 2002, Cardiovascular research.

[61]  G. Feld,et al.  Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation. , 1994, Circulation.

[62]  S. Zelenkofske,et al.  Value of the P‐Wave Signal‐Averaged ECG for Predicting Atrial Fibrillation After Cardiac Surgery , 1993, Circulation.

[63]  Yuchiao Chang,et al.  Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.

[64]  S. Connolly,et al.  Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation. , 2001, The American journal of cardiology.

[65]  K. Bailey,et al.  A Population Study of the Natural History of Wolff‐Parkinson‐White Syndrome in Olmsted Count, Minnesota, 1953‐1989 , 1993, Circulation.

[66]  J. Halperin,et al.  Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. , 1999, Stroke.

[67]  A. Laupacis,et al.  A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. , 2003, Archives of internal medicine.

[68]  H. White,et al.  Serum troponins T and I after elective cardioversion. , 2000, European heart journal.

[69]  J. Boineau,et al.  The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure. , 2003, The Journal of thoracic and cardiovascular surgery.

[70]  P. dos Santos,et al.  Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients. , 1992, The American journal of cardiology.

[71]  J. Rothrock,et al.  Cardioembolic vs. Noncardioembolic Strokes in Atrial Fibrillation: Frequency and Effect of Antithrombotic Agents in the Stroke Prevention in Atrial Fibrillation Studies , 2000, Cerebrovascular Diseases.

[72]  Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation. , 1989, Journal of cardiovascular pharmacology.

[73]  D. Wood,et al.  Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine. , 1968, British heart journal.

[74]  R. Baroffio,et al.  A Randomised Study Comparing Digoxin and Propafenone in the Treatment of Recent Onset Atrial Fibrillation , 1995 .

[75]  L. Niskanen,et al.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.

[76]  J M de Bakker,et al.  Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation. , 2001, Journal of the American College of Cardiology.

[77]  R. Coleman,et al.  Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. , 1986, The American journal of cardiology.

[78]  M. Gold,et al.  Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. , 1996, The American journal of cardiology.

[79]  P. Vardas,et al.  Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study. , 1999, Journal of the American College of Cardiology.

[80]  C. Tai,et al.  Effects of radiofrequency catheter ablation on quality of life in patients with atrial flutter. , 1999, The American journal of cardiology.

[81]  A. Camm,et al.  Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.

[82]  M. Rosenqvist,et al.  Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. , 2001, European heart journal.

[83]  M. Ezekowitz,et al.  Department of Veterans Affairs Cooperative Studies Program Clinical Trial Comparing Combined Warfarin and Aspirin With Aspirin Alone in Survivors of Acute Myocardial Infarction: Primary Results of the CHAMP Study , 2002, Circulation.

[84]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[85]  F. Morady,et al.  Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. , 1998, The New England journal of medicine.

[86]  Holly Yu,et al.  Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[87]  M. Woodward,et al.  Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial , 2003, Stroke.

[88]  S. Olsson,et al.  Dispersion of atrial repolarization in patients with paroxysmal atrial fibrillation. , 2001, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[89]  G. Breithardt,et al.  Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. , 2004, European heart journal.

[90]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[91]  Ç. Erol,et al.  Antiarrhythmic effect of converting enzyme inhibitors in congestive heart failure. , 1994, International journal of cardiology.

[92]  C. Lau,et al.  Comparison Of Digoxin Versus Low‐Dose Amiodarone For Ventricular Rate Control In Patients With Chronic Atrial Fibrillation , 2001, Clinical and experimental pharmacology & physiology.

[93]  A. Gillinov,et al.  Advances in Surgical Treatment of Atrial Fibrillation , 2007, Cardiology clinics.

[94]  P. Vardas,et al.  Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans. , 2002, European heart journal.

[95]  L. Zaputović,et al.  Unmasking Effect of Propafenone on the Concealed Form of the Brugada Phenomenon , 2000, Pacing and clinical electrophysiology : PACE.

[96]  M. Dunn,et al.  Atrial mechanical performance following internal and external cardioversion of atrial fibrillation: its relationship to peripheral embolization and acute cerebrovascular accident. , 2002, Chest.

[97]  D. W. Cheung.  Pulmonary vein as an ectopic focus in digitalis-induced arrhythmia , 1981, Nature.

[98]  J. Seeger,et al.  Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation. , 1990, Archives of internal medicine.

[99]  B. Wożakowska-Kapłon.  Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. , 2004, The American journal of cardiology.

[100]  A. Mallet,et al.  Anticoagulant (Fluindione)-Aspirin Combination in Patients with High-Risk Atrial Fibrillation , 2001, Cerebrovascular Diseases.

[101]  L. Rydén,et al.  Chronic atrial fibrillation. Long-term results of direct current conversion. , 2009 .

[102]  A. Caruso,et al.  Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide. , 1995, Archives of internal medicine.

[103]  R. Pistelli,et al.  Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. , 1995, The American journal of medicine.

[104]  M. Lesser.  Safety and efficacy of in-office cardioversion for treatment of supraventricular arrhythmias. , 1990, The American journal of cardiology.

[105]  Y. Iesaka,et al.  Reentrant Tachycardia in Pulmonary Veins of Patients with Paroxysmal Atrial Fibrillation , 2003, Journal of cardiovascular electrophysiology.

[106]  M Gent,et al.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.

[107]  R. Poole,et al.  Left Atrial Spontaneous Echo Contrast Is Highly Associated With Previous Stroke in Patients With Atrial Fibrillation or Mitral Stenosis , 1993, Stroke.

[108]  Wen-Chung Yu,et al.  Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. , 2003, European heart journal.

[109]  N. Ammash,et al.  Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. , 1995, Journal of the American College of Cardiology.

[110]  S H Lee,et al.  Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. , 1999, Cardiovascular research.

[111]  J L Cox,et al.  An 8 1/2-year clinical experience with surgery for atrial fibrillation. , 1996, Annals of surgery.

[112]  E. Prystowsky,et al.  Management of atrial fibrillation: therapeutic options and clinical decisions. , 2000, The American journal of cardiology.

[113]  O. Paes de Almeida,et al.  The cardiac muscle in the pulmonary vein of the rat: a morphological and electrophysiological study. , 1975, Journal of morphology.

[114]  G. Ewy,et al.  Transthoracic impedance to defibrillator discharge. Effect of electrode size and electrode-chest wall interface. , 1973, Journal of electrocardiology.

[115]  J. Webster,et al.  Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhages. , 2000, QJM : monthly journal of the Association of Physicians.

[116]  John Calvin Reed,et al.  Myocardial cell death in fibrillating and dilated human right atria. , 1999, Journal of the American College of Cardiology.

[117]  P. Oettgen,et al.  Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. , 1995, Journal of the American College of Cardiology.

[118]  G. Taylor,et al.  Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. , 1987, The American journal of cardiology.

[119]  H. Krumholz,et al.  Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. , 1993, The New England journal of medicine.

[120]  P. Grayburn,et al.  Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography. , 1997, Circulation.

[121]  M. Nicholls,et al.  Effect of enalapril on ventricular arrhythmias in congestive heart failure. , 1985, The American journal of cardiology.

[122]  F. Paganelli,et al.  Antibodies Against Myosin in Sera of Patients with Idiopathic Paroxysmal Atrial Fibrillation , 1998, Journal of cardiovascular electrophysiology.

[123]  R. Falk,et al.  Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group. , 1995, American heart journal.

[124]  Haran Burri,et al.  Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. , 2003, Journal of the American College of Cardiology.

[125]  M. Chung,et al.  Cardioversion Guided by Transesophageal Echocardiography: The ACUTE Pilot Study: A Randomized, Controlled Trial , 1997, Annals of Internal Medicine.

[126]  C. Upshaw,et al.  Hemodynamic changes after cardioversion of chronic atrial fibrillation. , 1997, Archives of internal medicine.

[127]  A. Louhija,et al.  Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation. , 1970, British heart journal.

[128]  O. Benavente,et al.  Antiplatelet therapy to prevent stroke: risk of brain hemorrhage and efficacy in atrial fibrillation. , 1997, Journal of the neurological sciences.

[129]  H. Schunkert,et al.  Increased Myocardial Collagen Content in Transgenic Rats Overexpressing Cardiac Angiotensin-Converting Enzyme Is Related to Enhanced Breakdown of N-Acetyl-Ser-Asp-Lys-Pro and Increased Phosphorylation of Smad2/3 , 2004, Circulation.

[130]  H. Lambert,et al.  Effect of Electrode Length on Atrial Defibrillation Thresholds , 1998, Journal of cardiovascular electrophysiology.

[131]  L. Dreifus,et al.  Ventricular Fibrillation: A Possible Mechanism of Sudden Death in Patients with Wolff‐Parkinson‐White Syndrome , 1971, Circulation.

[132]  Gabriele Vicedomini,et al.  Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia A New Anatomic Approach for Curing Atrial Fibrillation , 2000 .

[133]  C. Robertson,et al.  Extreme tachycardia complicating the use of disopyramide in atrial flutter. , 1980, British heart journal.

[134]  S. Lévy,et al.  High energy transcatheter cardioversion of chronic atrial fibrillation. , 1988, Journal of the American College of Cardiology.

[135]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[136]  Bramahn . Singh,et al.  Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone. , 1999, Circulation.

[137]  R. Goldberg,et al.  Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. , 2003, The American journal of cardiology.

[138]  S. Nattel,et al.  Pharmacological Prevention of Atrial Tachycardia Induced Atrial Remodeling as a Potential Therapeutic Strategy , 2003, Pacing and clinical electrophysiology : PACE.

[139]  Vincenzo Santinelli,et al.  The Who, What, Why, and How‐To Guide for Circumferential Pulmonary Vein Ablation , 2004, Journal of cardiovascular electrophysiology.

[140]  R. Tracy,et al.  Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. , 1997, Stroke.

[141]  S. Connolly,et al.  The Canadian Registry of Atrial Fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation. , 1998, The American journal of cardiology.

[142]  J. Coromilas.  Obesity and atrial fibrillation: is one epidemic feeding the other? , 2004, JAMA.

[143]  S. Ogawa,et al.  β-Blockers are effective in congestive heart failure patients with atrial fibrillation , 2003 .

[144]  A. John Camm,et al.  Clinical Relevance of Silent Atrial Fibrillation: Prevalence, Prognosis, Quality of Life, and Management , 2000, Journal of Interventional Cardiac Electrophysiology.

[145]  A. Camm,et al.  Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. , 1995, Journal of the American College of Cardiology.

[146]  J. Cox.  Cardiac Surgery for Arrhythmias , 2004, Pacing and clinical electrophysiology : PACE.

[147]  Sonia S Anand,et al.  Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. , 1999, JAMA.

[148]  C. January,et al.  Adverse effects of low dose amiodarone: a meta-analysis. , 1997, Journal of the American College of Cardiology.

[149]  W. Lien,et al.  Significant mitral regurgitation is protective against left atrial spontaneous echo contrast formation, but not against systemic embolism. , 1994, Chest.

[150]  G. Feld.  Atrial fibrillation. Is there a safe and highly effective pharmacological treatment? , 1990, Circulation.

[151]  A. L. Wit,et al.  Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease. , 1984, Circulation.

[152]  J. Gorter,et al.  Major bleeding during anticoagulation after cerebral ischemia , 1999, Neurology.

[153]  R. Gibbons,et al.  Guidelines for the Management of Patients With Valvular Heart Disease Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease) , 1998 .

[154]  A. Waldo.  Angiotensin II Receptor Blockade Reduces New-Onset Atrial Fibrillation and Subsequent Stroke Compared to Atenolol: The Losartan Intervention for End Point Reduction in Hypertension (LIFE) Study , 2006 .

[155]  Prashanthan Sanders,et al.  Spectral Analysis Identifies Sites of High-Frequency Activity Maintaining Atrial Fibrillation in Humans , 2005, Circulation.

[156]  T. Sacchi,et al.  Female preponderance in ibutilide-induced torsade de pointes. , 2004, International journal of cardiology.

[157]  Mandeep Bhargava,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.

[158]  O. Alfieri,et al.  Atrio-Esophageal Fistula as a Complication of Percutaneous Transcatheter Ablation of Atrial Fibrillation , 2004, Circulation.

[159]  Y. Rudy,et al.  Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter. Insights into mechanisms. , 1994, Circulation research.

[160]  J. Mathew,et al.  A multicenter risk index for atrial fibrillation after cardiac surgery. , 2004, JAMA.

[161]  H. Mond,et al.  Left atrial "stunning" following radiofrequency catheter ablation of chronic atrial flutter. , 1998, Journal of the American College of Cardiology.

[162]  I. Khan.  Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation. , 2003, International journal of cardiology.

[163]  Mark A. Wood,et al.  Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation , 1996 .

[164]  H. Crijns,et al.  Atrial Ultrastructural Changes During Experimental Atrial Tachycardia Depend on High Ventricular Rate , 2004, Journal of cardiovascular electrophysiology.

[165]  J. Halperin,et al.  Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. , 2000, Journal of the American College of Cardiology.

[166]  Brian Olshansky,et al.  The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[167]  B. Gersh,et al.  Significant effects of atrioventricular node ablation and pacemaker implantation on left ventricular function and long-term survival in patients with atrial fibrillation and left ventricular dysfunction. , 2003, The American journal of cardiology.

[168]  G. Cramér.  Early and late results of conversion of atrial fibrillation with quinidine. A clinical and hemodynamic study. , 1968, Acta medica Scandinavica. Supplementum.

[169]  G. Naccarelli,et al.  Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. , 2003, The American journal of cardiology.

[170]  M. Bamoshmoosh,et al.  Effectiveness of intravenous propafenone for conversion of recent‐onset atrial fibrillation: A placebo‐controlled study , 1995, Clinical cardiology.

[171]  R. Habib,et al.  Obesity and Risk of New-Onset Atrial Fibrillation After Cardiac Surgery , 2005, Circulation.

[172]  A. Proclemer,et al.  Intravenous propafenone in paroxysmal atrial fibrillation: A randomized, placebo‐controlled, double‐blind, multicenter clinical trial , 1996 .

[173]  Prashanthan Sanders,et al.  Atrial Fibrillation Originating From Persistent Left Superior Vena Cava , 2004, Circulation.

[174]  M. Kinoshita,et al.  Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation. , 1997, Japanese circulation journal.

[175]  S. Connolly,et al.  How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. , 1996, Archives of internal medicine.

[176]  E. Flensted-Jensen.  Wolff-Parkinson-White syndrome. A long-term follow-up of 47 cases. , 2009 .

[177]  H. Heidbüchel,et al.  Different Patterns of Angiotensin II and Atrial Natriuretic Peptide Secretion in a Sheep Model of Atrial Fibrillation , 2001, Journal of cardiovascular electrophysiology.

[178]  Lippincott Williams Wilkins,et al.  ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2004 .

[179]  H. Crijns,et al.  Successful use of flecainide in atrial fibrillation with rapid ventricular rate in the Wolff-Parkinson-White syndrome. , 1988, American heart journal.

[180]  Beta-blockers are effective in congestive heart failure patients with atrial fibrillation. , 2003, Journal of cardiac failure.

[181]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[182]  W. Walsh,et al.  Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. , 1993, Journal of the American College of Cardiology.

[183]  V. Fuster,et al.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation , 2001 .

[184]  A. Waldo,et al.  Efficacy and safety of moricizine in the maintenance of sinus rhythm in patients with recurrent atrial fibrillation. , 2001, The American journal of cardiology.

[185]  A. Capucci,et al.  Reproducible efficacy of loading oral propafenone in restoring sinus rhythm in patients with paroxysmal atrial fibrillation. , 2003, The American journal of cardiology.

[186]  F. Esmailian,et al.  Atrial Extracellular Matrix Remodeling and the Maintenance of Atrial Fibrillation , 2004, Circulation.

[187]  A. Constantinesco,et al.  Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. , 1992, European heart journal.

[188]  P. Vardas,et al.  Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation. , 2004, The American journal of cardiology.

[189]  E. Kaufman,et al.  Occurrence and Characteristics of Stroke Events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study , 2005 .

[190]  L. Shaw,et al.  Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias. , 1997, The American journal of cardiology.

[191]  R. Bryg,et al.  Effect of pregnancy on pressure gradient in mitral stenosis. , 1989, The American journal of cardiology.

[192]  R. Page,et al.  Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. , 1994, Circulation.

[193]  B. Lown,et al.  New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge. , 1986, JAMA.

[194]  P. Brugada,et al.  Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation. , 1987, The American journal of cardiology.

[195]  Wen-Chung Yu,et al.  Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation. , 2000, Circulation.

[196]  R. Hart,et al.  Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 2000 .

[197]  J. Alpert,et al.  Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. , 1990, American heart journal.

[198]  M. Allessie,et al.  Mapping of atrial fibrillation. , 2001, Annali dell'Istituto superiore di sanita.

[199]  M. Brignole,et al.  Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. , 1997, Circulation.

[200]  R. Page,et al.  Initial energy for elective external cardioversion of persistent atrial fibrillation. , 2000, The American journal of cardiology.

[201]  Jeffrey S. Ginsberg,et al.  Use of antithrombotic agents during pregnancy. , 1992, Chest.

[202]  R. Ruffy,et al.  Treatment of atrial tachyarrhythmias and preexcitation syndrome with flecainide acetate. , 1988, The American journal of cardiology.

[203]  B. Maron,et al.  Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. , 1979, Circulation.

[204]  M. Enriquez-Sarano,et al.  Multiplane transesophageal echocardiography: image orientation, examination technique, anatomic correlations, and clinical applications. , 1993, Mayo Clinic proceedings.

[205]  M. Woodward,et al.  Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack , 2005, Stroke.

[206]  D. Singer,et al.  Stroke following coronary-artery bypass surgery. A case-control estimate of the risk from carotid bruits. , 1988, The New England journal of medicine.

[207]  C. Lau,et al.  Effects of ventricular rate regularization pacing on quality of life and symptoms in patients with atrial fibrillation (Atrial fibrillation symptoms mediated by pacing to mean rates [AF SYMPTOMS study]). , 2004, The American journal of cardiology.

[208]  H. Petri,et al.  [Discrepant effects of oral and intravenous verapamil on A-V conduction in patients with ventricular preexcitation and atrial fibrillation]. , 1983, Herz.

[209]  F. Martin,et al.  Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study. , 1997, European heart journal.

[210]  H. Diener,et al.  European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke 1 1 ESPS-2 Writing Committee , 1996, Journal of the Neurological Sciences.

[211]  T. Ganiats,et al.  Comparison of Quality of Well-Being scale and NYHA functional status classification in patients with atrial fibrillation. New York Heart Association. , 1998, American heart journal.

[212]  A. Sheikhzadeh,et al.  Transesophageal echocardiographic determinants of embolism in nonrheumatic atrial fibrillation , 1995, The International Journal of Cardiac Imaging.

[213]  G. Paxinos,et al.  Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. , 2003, The American journal of cardiology.

[214]  A. Natale,et al.  AV Node Ablation and Pacemaker Implantation After Withdrawal of Effective Rate‐Control Medications for Chronic Atrial Fibrillation: Effect on Quality of Life and Exercise Performance , 1999, Pacing and clinical electrophysiology : PACE.

[215]  B K Khandheria,et al.  Echocardiographic assessment of the left atrial appendage. , 1999, Journal of the American College of Cardiology.

[216]  D K Owens,et al.  The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. , 1996, Archives of internal medicine.

[217]  P. Wolf,et al.  Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. , 1987, Archives of internal medicine.

[218]  Ottavio Alfieri,et al.  Prevention of Iatrogenic Atrial Tachycardia After Ablation of Atrial Fibrillation: A Prospective Randomized Study Comparing Circumferential Pulmonary Vein Ablation With a Modified Approach , 2004, Circulation.

[219]  J. Cleland,et al.  Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? , 2003, Journal of the American College of Cardiology.

[220]  E. Ohman,et al.  Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. , 2001, Chest.

[221]  Y. Nakamura,et al.  Predictors of ischemic stroke in non-rheumatic atrial fibrillation. , 1996, International journal of cardiology.

[222]  J. L. Huang,et al.  Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation. , 1997, The American journal of cardiology.

[223]  N. Kanuru,et al.  Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. , 2002, Journal of the American College of Cardiology.

[224]  E. Michelson,et al.  The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. , 1983, American heart journal.

[225]  A. Mattioli,et al.  Left atrial size and function after spontaneous cardioversion of atrial fibrillation and their relation to N-terminal atrial natriuretic peptide. , 2003, The American journal of cardiology.

[226]  A. Capucci,et al.  Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study. , 2000, American Heart Journal.

[227]  E. Prystowsky.  Atrioventricular Node Reentry: Physiology and Radiofrequency Ablation , 1997, Pacing and clinical electrophysiology : PACE.

[228]  M. Schlüter,et al.  Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus. , 1986, Journal of the American College of Cardiology.

[229]  M. Rosenqvist,et al.  Effect of intravenous magnesium on heart rate and heart rate variability in patients with chronic atrial fibrillation. , 1999, The American journal of cardiology.

[230]  R. Kerber,et al.  Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. , 2002, Journal of the American College of Cardiology.

[231]  K. Berkin,et al.  Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. , 1997, Heart.

[232]  J. Hirsh,et al.  Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[233]  J Nyboe,et al.  Stroke incidence and risk factors for stroke in Copenhagen, Denmark. , 1988, Stroke.

[234]  A. Weyman,et al.  Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. , 1990, Circulation.

[235]  E. Lonn,et al.  Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention. , 2003, American heart journal.

[236]  Nobuo Fukuda,et al.  Relation of Age and Sex to Atrial Electrophysiological Properties in Patients with No History of Atrial Fibrillation , 2003, Pacing and clinical electrophysiology : PACE.

[237]  D. Grobbee,et al.  Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial , 2002, The Lancet.

[238]  Christopher Piorkowski,et al.  Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence , 2005, Circulation.

[239]  J. .. Abildskov,et al.  Observations on the Ventricular Dysrhythmia Associated with Atrial Fibrillation in the Dog Heart , 1964, Circulation research.

[240]  Wen-Chung Yu,et al.  Right Atrial Focal Atrial Fibrillation , 1999, Journal of cardiovascular electrophysiology.

[241]  J. Murabito,et al.  Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.

[242]  D. Wolbrette.  Treatment of arrhythmias during pregnancy. , 2003, Current women's health reports.

[243]  P. Tchou,et al.  Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. , 2000, Circulation.

[244]  K. J. Wagner.  Digoxin for converting recent-onset atrial fibrillation to sinus rhythm , 1987 .

[245]  R. Wanless,et al.  Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias. , 1997, American heart journal.

[246]  J. Brugada,et al.  Identification of a genetic locus for familial atrial fibrillation. , 1997, The New England journal of medicine.

[247]  M. Kinoshita,et al.  Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. , 2000, Japanese circulation journal.

[248]  P. Vardas,et al.  Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses. , 2004, Chest.

[249]  J. Halperin,et al.  Obliteration of the leftatrial appendage forprevention of thromboembolism , 2003 .

[250]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[251]  Gianni Tognoni,et al.  Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). , 2005 .

[252]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[253]  G. Lamas,et al.  Ventricular pacing or dual-chamber pacing for sinus-node dysfunction , 2002 .

[254]  F. Morady,et al.  Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation. , 1996, The American journal of cardiology.

[255]  H. Katayama,et al.  Contrast sonography for detection of vesicoureteral reflux , 1994, The Lancet.

[256]  Pharmacological approaches in the treatment of atrial fibrillation. , 2004, Current medicinal chemistry.

[257]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2002 .

[258]  G. Lupi,et al.  Left atrial appendage function assessed by transesophageal echocardiography before and on the day after elective cardioversion for nonvalvular atrial fibrillation. , 1998, The American journal of cardiology.

[259]  T E Cuddy,et al.  Atrial fibrillation and atrial flutter. , 1996, The Canadian journal of cardiology.

[260]  T. Hanlon.  Digoxin for converting recent-onset atrial fibrillation to sinus rhythm: Falk RH, Knowlton AA, Bernard SA, et al Ann Intern Med 106:503–506 Apr 1987 , 1987 .

[261]  M. Josephson,et al.  Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter. , 2004, American Journal of Cardiology.

[262]  H. Crijns,et al.  Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? , 2004, Journal of Molecular Medicine.

[263]  P. Sanders,et al.  Electrophysiologic and electroanatomic changes in the human atrium associated with age. , 2004, Journal of the American College of Cardiology.

[264]  B. Nørgaard,et al.  Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled trial , 1999 .

[265]  E. Williams.  A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs , 1984 .

[266]  L. Kuller,et al.  Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[267]  Palle Petersen,et al.  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. , 2005, JAMA.

[268]  G. Lip,et al.  Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors , 2002, Circulation.

[269]  S. Saksena,et al.  Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. , 1998, Journal of the American College of Cardiology.

[270]  J A ABILDSKOV,et al.  Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. , 1959, American heart journal.

[271]  D. Oral,et al.  Lengthening of intraatrial conduction time in atrial fibrillation and its relation with early recurrence of atrial fibrillation. , 2001, Japanese heart journal.

[272]  A. Capucci,et al.  Oral Propafenone To Convert Recent-Onset Atrial Fibrillation in Patients with and without Underlying Heart Disease , 1997, Annals of Internal Medicine.

[273]  S. Lévy,et al.  Classification system of atrial fibrillation. , 2000, Current opinion in cardiology.

[274]  B. Olshansky,et al.  Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia , 2004, Circulation.

[275]  R. M. Payne,et al.  Management of Arrhythmias in Patients with Severe Lung Disease , 1994 .

[276]  U. Goldbourt,et al.  Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction , 1992 .

[277]  A Laupacis,et al.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.

[278]  G. Nante,et al.  Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation. , 1998, The American journal of cardiology.

[279]  J. Alpert,et al.  Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. , 2001, Chest.

[280]  Keishi Kubo,et al.  Role of Autonomic Tone in the Initiation and Termination of Paroxysmal Atrial Fibrillation in Patients Without Structural Heart Disease , 2003, Journal of cardiovascular electrophysiology.

[281]  H. White,et al.  Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation : stroke prevention in atrial fibrillation II study. Commentary , 1994 .

[282]  M. Pfeffer,et al.  Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. , 2006, Journal of the American College of Cardiology.

[283]  M. Niebauer,et al.  Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. , 1994, The New England journal of medicine.

[284]  J B Martins,et al.  Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment. , 1988, Circulation.

[285]  Margaret C Fang,et al.  Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation , 2004, Annals of Internal Medicine.

[286]  P. Sager,et al.  Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. , 1996, Journal of the American College of Cardiology.

[287]  M. A. Kaplan,et al.  Ventricular fibrillation in the Wolff-Parkinson-White syndrome. , 1969, The American journal of cardiology.

[288]  B. Maron,et al.  Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.

[289]  D. Wyse,et al.  Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. , 2002, Journal of the American College of Cardiology.

[290]  I. Khan.  Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. , 2001, Journal of the American College of Cardiology.

[291]  I. Black.  Spontaneous Echo Contrast: Where There's Smoke There's Fire , 2000, Echocardiography.

[292]  S Nattel,et al.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.

[293]  C. Schmitt,et al.  Initial Experience with Intracardiac Atrial Defibrillation in Patients with Chronic Atrial Fibrillation , 1994, Pacing and clinical electrophysiology : PACE.

[294]  A. Sheikhzadeh,et al.  Detection of a Hypercoagulable State in Nonvalvular Atrial Fibrillation and the Effect of Anticoagulant Therapy , 1996, Thrombosis and Haemostasis.

[295]  J. Stockigt,et al.  Atrial fibrillation and arterial embolism in hyperthyroidism. , 1981, Australian and New Zealand journal of medicine.

[296]  H. Crijns,et al.  Recent Advances in Drug Therapy for Atrial Fibrillation , 2003, Journal of cardiovascular electrophysiology.

[297]  W. Maisel.  Autonomic modulation preceding the onset of atrial fibrillation. , 2003, Journal of the American College of Cardiology.

[298]  C. Tai,et al.  Prolonged fractionation of paced right atrial electrograms in patients with atrial flutter and fibrillation. , 2001, Journal of the American College of Cardiology.

[299]  J. Blanc,et al.  Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[300]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[301]  J Jalife,et al.  Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. , 2000, Circulation.

[302]  S. Cobbe,et al.  Chemical cardioversion of atrial fibrillation with intravenous dofetilide. , 1995, International journal of cardiology.

[303]  K. Stangl,et al.  Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. , 2000, Journal of the American College of Cardiology.

[304]  A. Aggarwal.  Amiodarone to prevent recurrence of atrial fibrillation. , 2000, The New England journal of medicine.

[305]  C. Lau,et al.  Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. , 2003, The American journal of cardiology.

[306]  R. Tieleman,et al.  VERDICT: The Verapamil versus Digoxin Cardioversion Trial: A Randomized Study on the Role of Calcium Lowering for Maintenance of Sinus Rhythm after Cardioversion of Persistent Atrial Fibrillation , 2001, Journal of cardiovascular electrophysiology.

[307]  M. Niemelä,et al.  Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation. , 2000, The American journal of cardiology.

[308]  E. Prystowsky,et al.  Occurrence of Atrial Fibrillation in Patients With Paroxysmal Supraventricular Tachycardia Due to Atrioventricular Nodal Reentry , 1990, Pacing and clinical electrophysiology : PACE.

[309]  J. Mcanulty,et al.  Reversal of Electrical Remodeling After Cardioversion of Persistent Atrial Fibrillation , 2004, Cardiovascular Electrophysiology.

[310]  M. Jensen-Urstad,et al.  factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation , 2001, Clinical cardiology.

[311]  R. Holder,et al.  Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm. , 1999, Circulation.

[312]  P. Petersen,et al.  Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. , 1999, Archives of internal medicine.

[313]  A. Capucci,et al.  Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. , 1992, The American journal of cardiology.

[314]  M. Horvat,et al.  Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. , 1990, The American journal of cardiology.

[315]  D. Mehta,et al.  Thromboembolism following cardioversion of "common" atrial flutter. Risk factors and limitations of transesophageal echocardiography. , 1996, Chest.

[316]  S. Hohnloser,et al.  Beta-blocker therapy in atrial fibrillation. , 2003, Pacing and clinical electrophysiology : PACE.

[317]  H. Crijns,et al.  Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease. , 1993, Journal of the American College of Cardiology.

[318]  D. Packer,et al.  Left Atrial Appendage Obliteration in Atrial Fibrillation Thoracoscopic Extracardiac Obliteration of the Left Atrial Appendage for Stroke Risk Reduction in Atrial Fibrillation , 2003 .

[319]  A. Natale,et al.  Usefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation. , 1999, The American journal of cardiology.

[320]  J. Halperin,et al.  Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V). , 2003, American heart journal.

[321]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[322]  M. Brodsky,et al.  Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium. , 1987, The American journal of cardiology.

[323]  Paul A Friedman,et al.  Association of Atrial Fibrillation and Obstructive Sleep Apnea , 2004, Circulation.

[324]  J Clémenty,et al.  Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. , 2000, Circulation.

[325]  M. Allessie,et al.  Electrical, contractile and structural remodeling during atrial fibrillation. , 2002, Cardiovascular research.

[326]  W. Manning,et al.  Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. , 1989, Journal of the American College of Cardiology.

[327]  Douglas Packer,et al.  Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation.

[328]  C. Schmitt,et al.  Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. , 2001, European heart journal.

[329]  G. Naccarelli,et al.  Atrial Fibrillation in Heart Failure: , 2003, Journal of cardiovascular electrophysiology.

[330]  J. Thomas,et al.  Left atrial appendage "stunning" after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography. , 1995, American heart journal.

[331]  Hideyuki Hara,et al.  Monitoring the progression of the atrial electrical remodeling in patients with paroxysmal atrial fibrillation. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[332]  C. Giglioli,et al.  Propafenone versus amiodarone in field treatment of primary atrial tachydysrhythmias. , 1990, The Journal of emergency medicine.

[333]  R. Villareal,et al.  Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. , 2004, Journal of the American College of Cardiology.

[334]  E. V. Vaughan Williams.  A classification of antiarrhythmic actions reassessed after a decade of new drugs. , 1984, Journal of clinical pharmacology.

[335]  A. Camm,et al.  Classification of Atrial Fibrillation , 1997, The American journal of cardiology.

[336]  P. Schweitzer,et al.  Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. , 1998, The American journal of cardiology.

[337]  K. Stangl,et al.  Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillation , 1998, Heart.

[338]  C. Blomström-Lundqvist,et al.  Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. , 2000, Circulation.

[339]  S. Goldstein,et al.  Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. , 1988, Chest.

[340]  S. Nattel,et al.  Effects of Antiarrhythmic Drugs on Fibrillation in the Remodeled Atrium: Insights Into the Mechanism of the Superior Efficacy of Amiodarone , 2003, Circulation.

[341]  M. Domanski,et al.  Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.

[342]  Douglas L. Jones,et al.  Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. , 1995, Circulation.

[343]  S. Lévy,et al.  Predictors of In‐Hospital Mortality After DC Catheter Ablation of Atrioventricular Junction: Results of a Prospective, International, Multicenter Study , 1991, Circulation.

[344]  G. Mensah,et al.  Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999: Implications for Primary Prevention , 2003, Circulation.

[345]  E. Antman,et al.  Efficacy of intravenous propafenone for the acute management of atrial fibrillation. , 1989, The American journal of cardiology.

[346]  H. Crijns,et al.  Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. , 1993, The American journal of cardiology.

[347]  A. Goette,et al.  Atrial Amyloidosis: An Arrhythmogenic Substrate for Persistent Atrial Fibrillation , 2002, Circulation.

[348]  S Capewell,et al.  Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986--1996. , 2001, European heart journal.

[349]  J. McMurray,et al.  Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. , 1989, Journal of cardiovascular pharmacology.

[350]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[351]  T. Kamada,et al.  Increased intracardiovascular clotting in patients with chronic atrial fibrillation. , 1990, Journal of the American College of Cardiology.

[352]  Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter. , 2003 .

[353]  S. Lévy,et al.  Paroxysmal atrial fibrillation: a need for classification. , 1995, Journal of cardiovascular electrophysiology.

[354]  N. Rehnqvist,et al.  Sotalol versus quinidine in the maintenance of sinus rhythm after direct current conversion of atrial fibrillation , 1990, Cardiovascular Drugs and Therapy.

[355]  Bernhard Meier,et al.  Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. , 2005, Journal of the American College of Cardiology.

[356]  P. Boyden,et al.  The Effects on Atrial Electrophysiology and Structure of Surgically Induced Right Atrial Enlargement in Dogs , 1981, Circulation research.

[357]  G. Botto,et al.  External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements , 1999, Heart.

[358]  M. Woodward,et al.  EPIDEMIOLOGY OF COAGULATION FACTORS, INHIBITORS AND ACTIVATION MARKERS: THE THIRD GLASGOW MONICA SURVEY I. ILLUSTRATIVE REFERENCE RANGES BY AGE, SEX AND HORMONE USE , 1997, British journal of haematology.

[359]  J. Hirsh.  Oral anticoagulant drugs. , 1991, The New England journal of medicine.

[360]  J. Haefliger,et al.  Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. , 2001, Journal of the American College of Cardiology.

[361]  Peng-Sheng Chen,et al.  Selective Atrionodal Input Ablation for Induction of Proximal Complete Heart Block with Stable Junctional Escape Rhythm in Patients with Uncontrolled Atrial Fibrillation , 2003, Journal of Interventional Cardiac Electrophysiology.

[362]  Bruce M Psaty,et al.  Fish intake and risk of incident atrial fibrillation. , 2004, Circulation.

[363]  Stanley Nattel,et al.  New approaches to atrial fibrillation management: a critical review of a rapidly evolving field. , 2002, Drugs.

[364]  J. Goy,et al.  Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. , 1986, The American journal of cardiology.

[365]  C. Israel,et al.  Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. , 2004, Journal of the American College of Cardiology.

[366]  O. Orning,et al.  The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. , 1969, The American journal of cardiology.

[367]  T O Cheng,et al.  Predictors of atrial fibrillation after coronary artery surgery. , 1997, Circulation.

[368]  D. Scherf,et al.  Experimental studies on auricular flutter and auricular fibrillation. , 1948, American heart journal.

[369]  M. Jensen-Urstad,et al.  Transient Proarrhythmic State Following Atrioventricular Junctional Radiofrequency Ablation , 2002, Pacing and clinical electrophysiology : PACE.

[370]  E. Antman,et al.  Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. , 1990, Journal of the American College of Cardiology.

[371]  H. Calkins,et al.  A Randomized Comparison of External and Internal Cardioversion of Chronic Atrial Fibrillation , 1992, Circulation.

[372]  M. Brainin,et al.  Transesophageal Echocardiography To Assess Embolic Risk in Patients with Atrial Fibrillation , 1998, Annals of Internal Medicine.

[373]  S. Nattel,et al.  Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. , 2003, Cardiovascular research.

[374]  I. V. Van Gelder,et al.  Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. , 1999, The American journal of cardiology.

[375]  S. Connolly,et al.  Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT , 1997, The Lancet.

[376]  G F Michaud,et al.  Electrocardiographic differentiation of atrial flutter from atrial fibrillation by physicians. , 1999, Journal of electrocardiology.

[377]  G. Kay,et al.  Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. , 1996, Circulation.

[378]  R. Marinchak,et al.  Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. , 1992, The American journal of cardiology.

[379]  P. Kowey,et al.  Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. , 1999, Circulation.

[380]  W. Maisel,et al.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. , 2003, The American journal of cardiology.

[381]  P. Mills,et al.  The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. , 1997, Heart.

[382]  M A Waclawiw,et al.  Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.

[383]  A. Pezzano,et al.  Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation. , 1997, Circulation.

[384]  P. Ellinor,et al.  Locus for Atrial Fibrillation Maps to Chromosome 6q14‐16 , 2003, Circulation.

[385]  Marlene R. Miller,et al.  Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials. , 2000, The Journal of family practice.

[386]  Bruce M Psaty,et al.  Inflammation as a Risk Factor for Atrial Fibrillation , 2003, Circulation.

[387]  F L Meijler,et al.  Effect of right ventricular pacing on ventricular rhythm during atrial fibrillation. , 1988, Journal of the American College of Cardiology.

[388]  L. Lai,et al.  Clinical implications of left atrial appendage flow patterns in nonrheumatic atrial fibrillation. , 1994, Chest.

[389]  M. Frenneaux,et al.  Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. , 1990, Journal of the American College of Cardiology.

[390]  J. Messenger,et al.  A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). , 2003, Journal of the American College of Cardiology.

[391]  L Goldman,et al.  Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. , 1989, The American journal of medicine.

[392]  R. Hart,et al.  Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas , 2005, Stroke.

[393]  P. Dorian,et al.  Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation. , 2003, Cardiac electrophysiology review.

[394]  P. Vardas,et al.  Efficacy of amiodarone for the termination of persistent atrial fibrillation. , 1999, The American journal of cardiology.

[395]  J. Roelandt,et al.  Transthoracic echo/Doppler in the identification of patients with chronic non-valvular atrial fibrillation at risk for thromboembolic events. , 1994, European heart journal.

[396]  G. Tsivgoulis,et al.  Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study. , 2005, Age and ageing.

[397]  Theoretical possibilities for the development of novel antiarrhythmic drugs. , 2004, Current medicinal chemistry.

[398]  B. Marino,et al.  Ventricular conduction defects and atrial fibrillation after coronary artery bypass grafting. Multivariate analysis of preoperative, intraoperative and postoperative variables. , 1991, European heart journal.

[399]  M. Josephson,et al.  Amiodarone versus sotalol for atrial fibrillation. , 2005, The New England journal of medicine.

[400]  B. Maron,et al.  Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. , 1999, JAMA.

[401]  Paul A Friedman,et al.  Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the , 2005, Circulation.

[402]  E. W. Hancock,et al.  Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. , 1968, Annals of internal medicine.

[403]  R. Page,et al.  Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation. , 2003, The American journal of cardiology.

[404]  I. V. Van Gelder,et al.  Beta-blockers prevent subacute recurrences of persistent atrial fibrillation only in patients with hypertension. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[405]  R. Stroobandt,et al.  Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators. , 1997, The American journal of cardiology.

[406]  J. Soler‐Soler,et al.  Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. , 1996, Journal of the American College of Cardiology.

[407]  D. Fatkin,et al.  Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. , 1994, Journal of the American College of Cardiology.

[408]  M. Huttunen,et al.  Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial). , 1995, The American journal of cardiology.

[409]  P. Wolf,et al.  Epidemiologic assessment of chronic atrial fibrillation and risk of stroke , 1978, Neurology.

[410]  S. Connolly,et al.  Usefulness of propafenone for recurrent paroxysmal atrial fibrillation. , 1989, The American journal of cardiology.

[411]  K. Nademanee,et al.  A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. , 2004, Journal of the American College of Cardiology.

[412]  S. Adler,et al.  Prevention of Chronic Atrial Fibrillation by Pacing in the Region of Bachmann's Bundle: Results of a Multicenter Randomized Trial , 2001, Journal of cardiovascular electrophysiology.

[413]  T. Ives,et al.  Mexiletine use in pregnancy and lactation. , 1987, American journal of obstetrics and gynecology.

[414]  A. Goette,et al.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2000, Journal of the American College of Cardiology.

[415]  S M Nazarian,et al.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.

[416]  S. Sandhu,et al.  Optimal sampling interval to estimate heart rate at rest and during exercise in atrial fibrillation. , 1989, The American journal of cardiology.

[417]  Federico Lombardi,et al.  Autonomic nervous system and paroxysmal atrial fibrillation: a study based on the analysis of RR interval changes before, during and after paroxysmal atrial fibrillation. , 2004, European heart journal.

[418]  J. Halperin,et al.  Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. , 1993, The American journal of cardiology.

[419]  J. Blumenthal,et al.  Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia. , 1994, The American journal of cardiology.

[420]  M. Rubenfire,et al.  Amiodarone in the management of refractory atrial fibrillation. , 1987, Archives of internal medicine.

[421]  M. Allessie,et al.  Length of Excitation Wave and Susceptibility to Reentrant Atrial Arrhythmias in Normal Conscious Dogs , 1988, Circulation research.

[422]  B. Lown,et al.  Cardioversion and Digitalis Drugs: Changed Threshold to Electric Shock in Digitalized Animals , 1965, Circulation research.

[423]  [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison]. , 1994, Zeitschrift fur Kardiologie.

[424]  N. Ammash,et al.  Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographics tudy , 1995 .

[425]  C Warlow,et al.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[426]  A. Camm,et al.  Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. , 1999, The New England journal of medicine.

[427]  A. Capucci,et al.  A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. , 1994, International journal of cardiology.

[428]  B. Buxton,et al.  Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? , 1989, The Journal of thoracic and cardiovascular surgery.

[429]  T. Hedner,et al.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study , 1999, The Lancet.

[430]  Bernard Rosner,et al.  The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.

[431]  P. Thompson,et al.  EMBOLISM IN THYROTOXIC ATRIAL FIBRILLATION , 1979, The Medical journal of Australia.

[432]  P. Podrid.  Prevention of postoperative atrial fibrillation: what is the best approach? , 1999, Journal of the American College of Cardiology.

[433]  K. Harjai,et al.  Mechanical dysfunction of the left atrium and the left atrial appendage following cardioversion of atrial fibrillation and its relation to total electrical energy used for cardioversion. , 1998, The American journal of cardiology.

[434]  R. Beyth,et al.  A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin , 2000, Annals of Internal Medicine.

[435]  J. Halperin,et al.  Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. , 1999, American heart journal.

[436]  N. Edelman,et al.  Research fellowships in pulmonary and critical care. , 2002, Chest.

[437]  J. Gardin,et al.  Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). , 1994, The American journal of cardiology.

[438]  C. Tai,et al.  Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. , 1999, Circulation.

[439]  Cynthia A. Carnes,et al.  C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.

[440]  G. Klein,et al.  Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome. , 1983, American heart journal.

[441]  Pablo A. Chiale,et al.  Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial , 2001, Journal of cardiovascular pharmacology and therapeutics.

[442]  S. Connolly,et al.  Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. , 2005, American Heart Journal.

[443]  P. Kligfield,et al.  Variability of the ventricular response in atrial fibrillation and prognosis in chronic nonischemic mitral regurgitation. , 1994, The American journal of cardiology.

[444]  R. Crampton,et al.  Accepted, controversial, and speculative aspects of ventricular defibrillation. , 1980, Progress in cardiovascular diseases.

[445]  P. Coumel.  Neural aspects of paroxysmal atrial fibrillation , 1992 .

[446]  A. Capucci,et al.  Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. , 2001, American heart journal.

[447]  J. Bosch,et al.  Use of ramipril in preventing stroke: double blind randomised trial , 2002, BMJ : British Medical Journal.

[448]  M. Bulsara,et al.  The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). , 2003, Journal of the American College of Cardiology.

[449]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[450]  Therapy for atrial fibrillation: control of the ventricular response and prevention of recurrence. , 1995, Coronary artery disease.

[451]  A. Labovitz,et al.  Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. , 1991, Journal of the American College of Cardiology.

[452]  Anders Odén,et al.  Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal. , 2006, Thrombosis research.

[453]  E. Antman,et al.  Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. , 1991, Circulation.

[454]  M. Jazayeri,et al.  The Impact of Atrial Prevention and Termination Therapies on Atrial Tachyarrhythmia Burden in Patients Receiving a Dual-Chamber Defibrillator for Ventricular Arrhythmias , 2004, Journal of Interventional Cardiac Electrophysiology.

[455]  P. Kowey,et al.  Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. , 1998, Journal of the American College of Cardiology.

[456]  D. Zipes,et al.  Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of BAY K 8644. , 1992, Journal of the American College of Cardiology.

[457]  M. Brodsky,et al.  Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study , 2000, Circulation.

[458]  J. Hobbins,et al.  Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. , 1983, The American journal of cardiology.

[459]  SamuelLévy,et al.  Low-Energy Cardioversion of Spontaneous Atrial Fibrillation , 1997 .

[460]  G. Boriani,et al.  Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. , 2004, European heart journal.

[461]  D. Singer,et al.  Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. , 1991, The American journal of medicine.

[462]  R. Platt,et al.  Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. , 2003, Journal of the American College of Cardiology.

[463]  Z. J. Lipowski.  Letter: Psychosomatic medicine. , 1974, Lancet.

[464]  J. Agmon,et al.  Atrial fibrillation. Cause and time of onset. , 1989, Archives of internal medicine.

[465]  L. Mestroni.  Genomic medicine and atrial fibrillation. , 2003, Journal of the American College of Cardiology.

[466]  J. Dernellis,et al.  C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation , 2001, Acta cardiologica.

[467]  D P Zipes,et al.  Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling. , 1996, Circulation.

[468]  R. Steeds,et al.  An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation , 1999, Heart.

[469]  V. Fuster,et al.  Spontaneous echo contrast videodensity is flow-related and is dependent on the relative concentrations of fibrinogen and red blood cells. , 2003, Journal of the American College of Cardiology.

[470]  R. Ganam,et al.  Clinical course of recent-onset atrial fibrillation treated with oral propafenone. , 1994, Chest.

[471]  H. Crijns,et al.  Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure. , 1998, International journal of cardiology.

[472]  A. Adgey,et al.  Electrode pad size, transthoracic impedance and success of external ventricular defibrillation. , 1989, The American journal of cardiology.

[473]  P B Corr,et al.  The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. , 1991, The Journal of thoracic and cardiovascular surgery.

[474]  Michel Haïssaguerre,et al.  Distinctive Electrophysiological Properties of Pulmonary Veins in Patients With Atrial Fibrillation , 2002, Circulation.

[475]  B. Drew,et al.  Risk of thromboembolism in chronic atrial flutter. , 1997, The American journal of cardiology.

[476]  R. Lazzara,et al.  Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. , 1991, The New England journal of medicine.

[477]  T. Cheng.  Clinical Disorders of the Heart Beat , 1971 .

[478]  A. Pietersen,et al.  Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group. , 1991, The American journal of cardiology.

[479]  Kenneth A. Ellenbogen,et al.  The Ablate and Pace Trial: A Prospective Study of Catheter Ablation of the AV Conduction System and Permanent Pacemaker Implantation for Treatment of Atrial Fibrillation , 2004, Journal of Interventional Cardiac Electrophysiology.

[480]  M. Chang,et al.  Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. , 1995, European heart journal.

[481]  Hendrik Bonnemeier,et al.  Autonomic tone variations before the onset of paroxysmal atrial fibrillation. , 2003, Circulation.

[482]  R. Page,et al.  Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program. , 2001, American heart journal.

[483]  The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial. , 2004, Journal of the American College of Cardiology.

[484]  H. Crijns,et al.  Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. , 1995, Journal of cardiac failure.

[485]  R. Barr,et al.  Spread of excitation from the atrium into thoracic veins in human beings and dogs. , 1972, The American journal of cardiology.

[486]  K. Lie,et al.  The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. , 1990, Journal of the American College of Cardiology.

[487]  K. Ellenbogen,et al.  Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. , 1998, The American journal of cardiology.

[488]  A. Nussbacher,et al.  Atrial fibrillation in endomyocardial fibrosis is a marker of worse prognosis. , 1998, International journal of cardiology.

[489]  P. Gates,et al.  Asymptomatic cerebral infarction in patients with chronic atrial fibrillation. , 1988, Stroke.

[490]  M. Enriquez-Sarano,et al.  Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. , 2000, Journal of the American College of Cardiology.

[491]  M. Shenasa,et al.  Evaluation of flecainide acetate in rapid atrial fibrillation complicating wolff‐parkinson‐white syndrome , 1985, Clinical cardiology.

[492]  J. Halperin,et al.  Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. , 1998, Journal of the American College of Cardiology.

[493]  L. E. Peterson,et al.  Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study. , 1988, European heart journal.

[494]  E. Pritchett,et al.  Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group. , 1989, Circulation.

[495]  A. Goette,et al.  Expression and activity of ectopeptidases in fibrillating human atria. , 2001, Journal of molecular and cellular cardiology.

[496]  M. Allessie,et al.  Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation , 1985 .

[497]  S. Bertil Olsson,et al.  Atrial Fibrillation: Mechanisms and Therapeutic Strategies , 1994 .

[498]  J. Mathew,et al.  Prophylaxis against postoperative atrial fibrillation: current progress and future directions. , 2005, JAMA.

[499]  G. Klein,et al.  Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern. , 1990, Circulation.

[500]  A. Bloch,et al.  Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension. , 2000, American heart journal.

[501]  G. Lip,et al.  Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease , 2005, Thrombosis and Haemostasis.

[502]  M. Franz,et al.  Risk of Stroke in Patients With Atrial Flutter , 2001 .

[503]  J. Williams,et al.  Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group. , 1999, The American journal of cardiology.

[504]  T. Horinouchi,et al.  C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? , 2004, Japanese heart journal.

[505]  I. V. Van Gelder,et al.  Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. , 2000, European heart journal.

[506]  A. Zaman,et al.  Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation. , 2004, American heart journal.

[507]  W. Lehmacher,et al.  Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial , 2004, Circulation.

[508]  P B Corr,et al.  The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. , 1991, The Journal of thoracic and cardiovascular surgery.

[509]  G. Naccarelli,et al.  Atrial fibrillation in heart failure: prognostic significance and management. , 2003 .

[510]  Shih-AnnChen,et al.  Catheter Ablation of Paroxysmal Atrial Fibrillation Initiated by Non–Pulmonary Vein Ectopy , 2003 .

[511]  T. Petty,et al.  Arrhythmias associated with acute respiratory failure in patients with chronic airway obstruction. , 1973, Chest.

[512]  P. Vardas,et al.  Sinus Pacemaker Function after Cardioversion of Chronic Atrial Fibrillation: Is Sinus Node Remodeling Related with Recurrence? , 2001, Journal of cardiovascular electrophysiology.

[513]  G Van Nooten,et al.  Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. , 1998, The American journal of cardiology.

[514]  K. Arakawa,et al.  Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. , 2003, Journal of the American College of Cardiology.

[515]  Ottavio Alfieri,et al.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. , 2003, Journal of the American College of Cardiology.

[516]  P. Vardas,et al.  Effects of Amiodarone and Diltiazem on Persistent Atrial Fibrillation Conversion and Recurrence Rates: A Randomized Controlled Study , 2004, Cardiovascular Drugs and Therapy.

[517]  H. Heidbuchel,et al.  Atrial fibrillation after radiofrequency ablation of atrial flutter: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics , 2004, Heart.

[518]  G. Ayers,et al.  Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. , 1994, Circulation.

[519]  S. Spinler,et al.  Conversion of Recent‐Onset Atrial Fibrillation with Intravenous Amiodarone: A Meta‐Analysis of Randomized Controlled Trials , 2002, Pharmacotherapy.

[520]  B. Gage,et al.  Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin , 2004, Circulation.

[521]  Y C Chen,et al.  Effects of Rapid Atrial Pacing on the Arrhythmogenic Activity of Single Cardiomyocytes From Pulmonary Veins: Implication in Initiation of Atrial Fibrillation , 2001, Circulation.

[522]  J. Rothrock,et al.  Ischemic stroke in patients with atrial fibrillation , 1993, Neurology.

[523]  G. Naccarelli,et al.  Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. , 2000, The American journal of cardiology.

[524]  A. Camm,et al.  Mortality in Patients After a Recent Myocardial Infarction: A Randomized, Placebo-Controlled Trial of Azimilide Using Heart Rate Variability for Risk Stratification , 2004, Circulation.

[525]  N. Saoudi,et al.  Radiofrequency catheter ablation of common atrial flutter: significance of palpitations and quality-of-life evaluation in patients with proven isthmus block. , 1999, Circulation.

[526]  G. Rosenhamer,et al.  Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm. , 1975, British heart journal.

[527]  Douglas L Packer,et al.  Progress in Nonpharmacologic Therapy of Atrial Fibrillation , 2003, Journal of cardiovascular electrophysiology.

[528]  L. Wilkins.  European Stroke Prevention Study. ESPS Group. , 1990, Stroke.

[529]  D. Lin,et al.  Increased Intensity of Anticoagulation May Reduce Risk of Thrombus During Atrial Fibrillation Ablation Procedures in Patients with Spontaneous Echo Contrast , 2005, Journal of cardiovascular electrophysiology.

[530]  S. Lévy,et al.  Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. , 1998, European heart journal.

[531]  W. Manning,et al.  Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. , 1995, The American journal of cardiology.

[532]  Maurits A. Allessie,et al.  Reverse Structural and Gap-Junctional Remodeling After Prolonged Atrial Fibrillation in the Goat , 2003, Circulation.

[533]  A. Skanes,et al.  Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation. , 2001, American heart journal.

[534]  J. Halperin,et al.  Obliteration of the left atrial appendage for prevention of thromboembolism. , 2003, Journal of the American College of Cardiology.

[535]  E. Michelson,et al.  Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. , 1989, The American journal of cardiology.

[536]  Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction. , 2004 .

[537]  P. Vardas,et al.  Acute comparative effect of right and left ventricular pacing in patients with permanent atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[538]  M. Di leo,et al.  Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation. , 1999, The American journal of cardiology.

[539]  J. Blanc,et al.  Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation. PARSIFAL Study Group. , 1999, The American journal of cardiology.

[540]  J. Dale,et al.  Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study. , 1971, British heart journal.

[541]  S. Connolly,et al.  Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators. , 2000, Journal of the American College of Cardiology.

[542]  M. Gasparini,et al.  Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. , 1999, Journal of the American College of Cardiology.

[543]  J. McMurray,et al.  Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. , 2005, Journal of the American College of Cardiology.

[544]  A. Laupacis,et al.  A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. , 1993, The New England journal of medicine.

[545]  A. Salvador,et al.  Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study. , 2004, Journal of the American College of Cardiology.

[546]  H. Crijns,et al.  Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter. , 2000, The American journal of cardiology.

[547]  S. Olsson,et al.  Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation. , 2009, Acta medica Scandinavica.

[548]  A. Capucci,et al.  Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. , 1995, Chest.

[549]  G. Lip,et al.  Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation , 2004, Heart.

[550]  Stanley Nattel,et al.  Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs , 2004, Circulation.

[551]  Andrew S. Mugglin,et al.  Combined Efficacy of Atrial Septal Lead Placement and Atrial Pacing Algorithms for Prevention of Paroxysmal Atrial Tachyarrhythmia , 2003, Journal of cardiovascular electrophysiology.

[552]  J. Halperin,et al.  Atrial fibrillation and stroke: new ideas, persisting dilemmas. , 1988, Stroke.

[553]  G. Dobb,et al.  Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide. , 1991, The American journal of cardiology.

[554]  Prashanthan Sanders,et al.  Techniques for Curative Treatment of Atrial Fibrillation , 2004, Journal of cardiovascular electrophysiology.

[555]  R. Langendorf,et al.  Ventricular Response in Atrial Fibrillation: Role of Concealed Conduction in the AV Junction , 1965, Circulation.

[556]  M Fukunami,et al.  Detection of Patients at Risk for Paroxysmal Atrial Fibrillation During Sinus Rhythm by P Wave‐Triggered Signal‐Averaged Electrocardiogram , 1991, Circulation.

[557]  K A Schulman,et al.  Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. , 2000, Circulation.

[558]  L. Goldman,et al.  Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.

[559]  P. Venugopalan,et al.  Left atrial spontaneous echo contrast in patients with rheumatic mitral valve stenosis in sinus rhythm: relationship to mitral valve and left atrial measurements. , 2001, International journal of cardiology.

[560]  B. Winters,et al.  &ggr;‐Adrenergic Blockade Accelerates Conversion of Postoperative Supraventricular Tachyarrhythmias , 1998, Anesthesiology.

[561]  M. Blombäck,et al.  Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. , 1990, Stroke.

[562]  Frank Bogun,et al.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation. , 2006, The New England journal of medicine.

[563]  M R Franz,et al.  Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. , 1997, Journal of the American College of Cardiology.

[564]  K. Lees,et al.  Identification of echocardiographic "smoke" in a bench model with transcranial Doppler ultrasound. , 2000, Stroke.

[565]  H. Åberg,et al.  Direct current countershock complications. , 2009, Acta medica Scandinavica.

[566]  S. Fihn,et al.  The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin , 1996, Annals of Internal Medicine.

[567]  S. Lévy,et al.  Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[568]  G. Uijen,et al.  Aspirin Plus Coumarin Versus Aspirin Alone in the Prevention of Reocclusion After Fibrinolysis for Acute Myocardial Infarction: Results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial , 2002, Circulation.

[569]  G. Kay,et al.  Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[570]  F. Pelosi,et al.  Effect of diltiazem on the recurrence rate of paroxysmal atrial fibrillation. , 2001, The American journal of cardiology.

[571]  S. Hohnloser,et al.  Atrial fibrillation--maintaining sinus rhythm versus ventricular rate control: the PIAF trial. Pharmacological Intervention in Atrial Fibrillation. , 1998, Journal of cardiovascular electrophysiology.

[572]  S. Bendahhou,et al.  Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. , 2004, American journal of human genetics.

[573]  Silvia G Priori,et al.  ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co , 2003, Circulation.

[574]  R McBride,et al.  Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. , 1999, Stroke.

[575]  C. Tai,et al.  Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double‐blind, randomized trial , 1996, Journal of internal medicine.

[576]  W. Manning,et al.  Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. , 1994, Journal of the American College of Cardiology.

[577]  Yuchiao Chang,et al.  Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.

[578]  B. Herweg,et al.  Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. , 1998, The American journal of cardiology.

[579]  R Lazzara,et al.  Focal Atrial Fibrillation: Experimental Evidence for a Pathophysiologic Role of the Autonomic Nervous System , 2001, Journal of cardiovascular electrophysiology.

[580]  Carl van Walraven,et al.  Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. , 2002, JAMA.

[581]  H. Crijns,et al.  Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. , 1992, JAMA.

[582]  S. Olsson,et al.  Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial , 2003, The Lancet.

[583]  G. Lip,et al.  Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study). , 2002, The American journal of cardiology.

[584]  S. Connolly,et al.  Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials. , 2003, American heart journal.

[585]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[586]  J. Knottnerus,et al.  Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin , 1999, BMJ.

[587]  M. Haissaguerre,et al.  Nonpulmonary Vein Foci: , 2003, Pacing and clinical electrophysiology : PACE.

[588]  R. Damiano,et al.  A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. , 2004, The Journal of thoracic and cardiovascular surgery.

[589]  M Gent,et al.  Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes , 2000 .

[590]  S. Hohnloser,et al.  New Antiarrhythmic Drugs for the Treatment of Atrial Fibrillation , 2008, Herz Kardiovaskuläre Erkrankungen.

[591]  Jyh‐Hong Chen,et al.  Natural history of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. , 1997, The American journal of cardiology.

[592]  F A Mathewson,et al.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[593]  F. Loop,et al.  Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. , 1992, Journal of the American College of Cardiology.

[594]  R. Ashman,et al.  Auricular fibrillation with aberration simulating ventricular paroxysmal tachycardia. , 1947, American heart journal.

[595]  S. Hohnloser,et al.  Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group. , 1996, The American journal of cardiology.

[596]  P. Kowey,et al.  Clinical Outcome of Patients Who Develop PAF After CABG Surgery , 2001, Pacing and clinical electrophysiology : PACE.

[597]  J. McMurray,et al.  Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK , 2004, Heart.

[598]  B. Mcgovern,et al.  Antiarrhythmic drug therapy in pregnancy and lactation. , 1998, The American journal of cardiology.

[599]  F. Marchlinski,et al.  Presence of Left-to-Right Atrial Frequency Gradient in Paroxysmal but Not Persistent Atrial Fibrillation in Humans , 2004, Circulation.

[600]  J. Tamargo,et al.  Pharmacology of Cardiac Potassium Channels , 2003 .

[601]  B. Lown,et al.  The use of quinidine in cardioversion. , 1967, The American journal of cardiology.

[602]  P. Vardas,et al.  Pharmacological Cardioversion of Recent Onset Atrial Fibrillation with Intravenous Amiodarone in Patients Receiving Long-Term Amiodarone Therapy: Is It Reasonable? , 2003, Journal of Interventional Cardiac Electrophysiology.

[603]  J. Bermejo,et al.  Predictors of left atrial spontaneous echo contrast and thrombi in patients with mitral stenosis and atrial fibrillation. , 2000, The American journal of cardiology.

[604]  P. Harris,et al.  The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. , 1990, The Journal of thoracic and cardiovascular surgery.

[605]  A. Hedman,et al.  Predicting the risk of atrial fibrillation after coronary artery bypass surgery , 2003, Scandinavian cardiovascular journal : SCJ.

[606]  W. Manning,et al.  Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. , 1995, Circulation.

[607]  Progress Collaborative.  Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack , 2006 .

[608]  B. Hockings,et al.  Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. , 1995, The American journal of cardiology.

[609]  D. Singer,et al.  Factor V Leiden and Risk of Ischemic Stroke in Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 2003, Journal of Thrombosis and Thrombolysis.

[610]  L. Køber,et al.  The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution. , 1999, European heart journal.

[611]  A. Algra,et al.  Predictors of major vascular events in patients with a transient ischemic attack or minor ischemic stroke and with nonrheumatic atrial fibrillation. European Atrial Fibrillation Trial (EAFT) Study Group. , 1995, Stroke.

[612]  G. Guiraudon,et al.  The Pathology of Drug Resistant Lone Atrial Fibrillation in Eleven Surgically Treated Patients , 1992 .

[613]  W. M. Smith,et al.  Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations. , 1990, The Journal of thoracic and cardiovascular surgery.

[614]  M. Nieminen,et al.  Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. , 2005, Journal of the American College of Cardiology.

[615]  D. Singer,et al.  Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. , 2000, Circulation.

[616]  Douglas L Packer,et al.  Familial atrial fibrillation is a genetically heterogeneous disorder. , 2003, Journal of the American College of Cardiology.

[617]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[618]  H. Crijns,et al.  Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: A randomized, double-blind study , 1996, Cardiovascular Drugs and Therapy.

[619]  S. Hohnloser,et al.  Rhythm or rate control in atrial fibrillation-pharmacological intervention in atrial fibrillation (PIAF): a randomised trial , 2001 .

[620]  E. Prystowsky,et al.  Effect of continuous enhanced vagal tone on atrioventricular nodal and sinoatrial nodal function in humans. , 1991, Circulation research.

[621]  J Haaksma,et al.  Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? , 1998, Journal of the American College of Cardiology.

[622]  P. Petersen.  Thromboembolic complications in atrial fibrillation. , 1990, Stroke.

[623]  C. Lau,et al.  Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery. , 2000, Circulation.

[624]  E. Bernal,et al.  Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study , 2002, Circulation.

[625]  R. Zupkis,et al.  Antiarrhythmic effects of intravenous timolol in supraventricular arrhythmias , 1985, Clinical pharmacology and therapeutics.

[626]  S Nattel,et al.  Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. , 1996, Circulation research.

[627]  D. Zipes,et al.  Electrical properties of the thoracic veins. , 1972, The American journal of cardiology.

[628]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.

[629]  J. Delahaye,et al.  Controlled trial of a long-acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation. , 1981, European heart journal.

[630]  S. Lévy,et al.  Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results. , 1997, Circulation.

[631]  P. Vardas,et al.  Left ventricular mechanics during right ventricular apical or left ventricular-based pacing in patients with chronic atrial fibrillation after atrioventricular junction ablation. , 2004, Journal of the American College of Cardiology.

[632]  M. Kotler,et al.  Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by transesophageal echocardiography. , 1993, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[633]  P. Petersen,et al.  Stroke in thyrotoxicosis with atrial fibrillation. , 1988, Stroke.

[634]  A. Torbicki,et al.  Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. , 2004, Chest.

[635]  Lippincott Williams Wilkins,et al.  Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.

[636]  M. Jensen-Urstad,et al.  Transient proarrhythmic state following atrioventricular junction radiofrequency ablation: pathophysiologic mechanisms and recommendations for management. , 2002, The American journal of medicine.

[637]  M. Shenasa,et al.  Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. , 1988, The American journal of cardiology.

[638]  Harry J G M Crijns,et al.  Molecular mechanisms of remodeling in human atrial fibrillation. , 2002, Cardiovascular research.

[639]  L. Køber,et al.  Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy , 2001, Circulation.

[640]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[641]  R Lazzara,et al.  Catheter Ablation of Cardiac Autonomic Nerves for Prevention of Vagal Atrial Fibrillation , 2000, Circulation.

[642]  D. Bush,et al.  Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study). , 2004, The American journal of cardiology.

[643]  U. Tebbe,et al.  Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. , 2003, Journal of the American College of Cardiology.

[644]  C. Tai,et al.  Alterations of heart rate variability after radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins. , 1999, Circulation.

[645]  G. Jensen,et al.  Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). , 2003, The American journal of cardiology.

[646]  R. Cappato,et al.  Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia. , 2001, Journal of the American College of Cardiology.

[647]  K. Lindpaintner,et al.  Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[648]  R. Kerber,et al.  The Effects of Atrial Fibrillation on Atrial Pressure‐ Volume and Flow Relationships , 1982, Circulation research.

[649]  F. Morady,et al.  Comparison of Verapamil and Ibutilide for the Suppression of Immediate Recurrences of Atrial Fibrillation after Transthoracic Cardioversion , 2002, Journal of cardiovascular pharmacology and therapeutics.

[650]  K. Ellenbogen,et al.  Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. , 1997, Journal of the American College of Cardiology.

[651]  P. Oettgen,et al.  Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation. , 1995, Archives of internal medicine.

[652]  Bramahn . Singh,et al.  Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. , 1999, Journal of the American College of Cardiology.

[653]  T. Agner,et al.  A reevaluation of atrial fibrillation in thyrotoxicosis. , 1984, Danish medical bulletin.

[654]  Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. A prospective and randomized study ☆ , 2002 .

[655]  K. Ellenbogen,et al.  Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability. , 1996, Journal of the American College of Cardiology.

[656]  D. W. Cheung.  Electrical activity of the pulmonary vein and its interaction with the right atrium in the guinea‐pig. , 1981, The Journal of physiology.

[657]  P. Vestergaard,et al.  Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. , 2005, The American journal of medicine.

[658]  J. Hirsh,et al.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. , 1995, The New England journal of medicine.

[659]  G. Schlierf,et al.  Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin. , 1993, Seminars in thrombosis and hemostasis.

[660]  J. Alpert,et al.  Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. , 1992, Chest.

[661]  M. Guerrero,et al.  Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency , 2006, Intensive Care Medicine.

[662]  Michael Abdelnoor,et al.  Warfarin, aspirin, or both after myocardial infarction. , 2002, The New England journal of medicine.

[663]  Thomas Lavergne,et al.  Cost of care distribution in atrial fibrillation patients: the COCAF study , 2004 .

[664]  J. Boineau,et al.  Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results. , 1995, The Journal of thoracic and cardiovascular surgery.

[665]  J. Tijssen,et al.  Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. , 1993, The American journal of cardiology.

[666]  J. Kluger,et al.  Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation , 1991 .

[667]  K. Weber.  Fibrosis and hypertensive heart disease , 2000, Current opinion in cardiology.

[668]  S. Connolly,et al.  Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide. , 2003, Circulation.

[669]  W. Kannel,et al.  Coronary heart disease and atrial fibrillation: the Framingham Study. , 1983, American heart journal.

[670]  M. Rosen,et al.  The Relationship of Human Atrial Cellular Electrophysiology to Clinical Function and Ultrastructure , 1983, Circulation research.

[671]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[672]  Atul Verma,et al.  Pulmonary Vein Antrum Isolation: , 2004, Journal of cardiovascular electrophysiology.

[673]  A. Zanchetti,et al.  Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy , 2002, Journal of hypertension.

[674]  H. Wellens,et al.  Immediate Reinitiation of Atrial Fibrillation Following Internal Atrial Defibrillation , 1998, Journal of cardiovascular electrophysiology.

[675]  J Haaksma,et al.  Analysis of vagal effects on ventricular rhythm in patients with atrial fibrillation. , 1994, Clinical science.

[676]  B. Nørgaard,et al.  Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group. , 1999, American heart journal.

[677]  D. Schwartzman,et al.  Common Left Pulmonary Vein: , 2004, Journal of cardiovascular electrophysiology.

[678]  J Clémenty,et al.  A focal source of atrial fibrillation treated by discrete radiofrequency ablation. , 1997, Circulation.

[679]  I. V. Van Gelder,et al.  Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. , 1989, The American journal of cardiology.

[680]  Dietrich Andresen,et al.  Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. , 2005, European heart journal.

[681]  S. Meterissian,et al.  Assessment of cardiac function in patients who were morbidly obese. , 1990, Surgery.

[682]  Ralph B. D'Agostino,et al.  Parental Atrial Fibrillation as a Risk Factor for Atrial Fibrillation in Offspring , 2004 .

[683]  A. Camm,et al.  A Comparison of Intravenous Propafenone and Flecainide in the Treatment of Tachycardias Associated with the Wolff‐Parkinson‐White Syndrome , 1991, Pacing and clinical electrophysiology : PACE.

[684]  S. Yusuf,et al.  Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. , 2004, The Cochrane database of systematic reviews.

[685]  A. d'Avila,et al.  Left Atrial–Esophageal Fistula Following Radiofrequency Catheter Ablation of Atrial Fibrillation , 2004, Journal of cardiovascular electrophysiology.

[686]  A. Zbrozek,et al.  Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter. , 1993, The American journal of cardiology.

[687]  Martha J. Radford,et al.  Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .

[688]  E. Antman,et al.  Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. , 1993, The American journal of cardiology.

[689]  A L Waldo,et al.  Characterization of Atrial Flutter: Studies in Man After Open Heart Surgery Using Fixed Atrial Electrodes , 1979, Circulation.

[690]  D. Fatkin,et al.  Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. , 1994, Journal of the American College of Cardiology.

[691]  J. Le Heuzey,et al.  [The natural history of 270 cases of Wolff-Parkinson-White syndrome in a survey of the general population]. , 1989, Archives des maladies du coeur et des vaisseaux.

[692]  O. Alfieri,et al.  Pulmonary Vein Denervation Enhances Long-Term Benefit After Circumferential Ablation for Paroxysmal Atrial Fibrillation , 2004, Circulation.

[693]  S. Nattel.  New ideas about atrial fibrillation 50 years on , 2002, Nature.

[694]  G. Klein,et al.  Propafenone for prevention of recurrent atrial fibrillation. , 1988, The American journal of cardiology.

[695]  M. Mansour,et al.  Left-to-Right Gradient of Atrial Frequencies During Acute Atrial Fibrillation in the Isolated Sheep Heart , 2001, Circulation.

[696]  J. Kastrup,et al.  Cerebral Blood Flow before and after Cardioversion of Atrial Fibrillation , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[697]  J. Halperin,et al.  Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[698]  I. V. Van Gelder,et al.  Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone. , 2000, The American journal of cardiology.

[699]  Prashanthan Sanders,et al.  Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.

[700]  F. Dunn,et al.  Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index. , 1981, The American journal of cardiology.

[701]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[702]  M. Piccoli,et al.  Analysis of Heart Rate Variability Five Minutes Before the Onset of Paroxysmal Atrial Fibrillation , 1999, Pacing and clinical electrophysiology : PACE.

[703]  L. Tsai,et al.  Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation. , 1997, International journal of cardiology.

[704]  A. Goette,et al.  Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. , 2000, Circulation.

[705]  R. Grimm,et al.  Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation. , 2001, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[706]  D. Stakos,et al.  Atrial Fibrillation and Hypercoagulability: Dependent on Clinical Factors or/and on Genetic Alterations? , 2003, Journal of Thrombosis and Thrombolysis.

[707]  V. Fuster,et al.  Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. , 1996, Circulation.

[708]  M. Gammage,et al.  Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory paroxysmal atrial fibrillation , 1998, Heart.

[709]  Vince Paul,et al.  Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation. , 1999, The American journal of cardiology.

[710]  S. A. Levine,et al.  Auricular fibrillation without other evidence of heart disease; a cause of reversible heart failure. , 1949, The American journal of medicine.

[711]  A. Laupacis,et al.  Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No Previous History of Stroke or Transient Ischemic Attacks , 2005, The Cochrane database of systematic reviews.

[712]  M. Zimmermann,et al.  Fluctuation in Autonomic Tone is a Major Determinant of Sustained Atrial Arrhythmias in Patients with Focal Ectopy Originating from the Pulmonary Veins , 2001, Journal of cardiovascular electrophysiology.

[713]  A. Capucci,et al.  Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. , 1997, International journal of cardiology.

[714]  Burr Hall,et al.  Catheter Ablation for Paroxysmal Atrial Fibrillation: Segmental Pulmonary Vein Ostial Ablation Versus Left Atrial Ablation , 2003, Circulation.

[715]  W. Evans,et al.  LONE AURICULAR FIBRILLATION , 1954, British heart journal.

[716]  G. Rose,et al.  RISK OF STROKE IN NON-RHEUMATIC ATRIAL FIBRILLATION , 1987, The Lancet.

[717]  L. Tamariz,et al.  Pharmacological rate control of atrial fibrillation. , 2004, Cardiology clinics.

[718]  E. Prystowsky,et al.  Role of concealed and supernormal conductions during atrial fibrillation in the preexcitation syndrome. , 1991, The American journal of cardiology.

[719]  R. Schilling,et al.  Spontaneous termination of ventricular fibrillation , 2004, Heart.

[720]  H. Ogita,et al.  Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: a prospective study. , 2000, Journal of the American College of Cardiology.

[721]  Takashi Sugamori,et al.  High Plasma Brain Natriuretic Polypeptide Level as a Marker of Risk for Thromboembolism in Patients With Nonvalvular Atrial Fibrillation , 2002, Stroke.

[722]  H C Smith,et al.  Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. , 1992, The American journal of cardiology.

[723]  K. Ellenbogen,et al.  Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. , 1997, Circulation.

[724]  J. Pezzullo,et al.  Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. , 2003, The American journal of cardiology.

[725]  R. Schmieder,et al.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. , 2003, The American journal of medicine.

[726]  P. Wolf,et al.  Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. , 1985, JAMA.

[727]  J. Karliner,et al.  Safety of electrical cardioversion in patients without digitalis toxicity. , 1981, Annals of internal medicine.

[728]  Kenneth Egstrup,et al.  Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial , 2000, The Lancet.

[729]  K. Saku,et al.  The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. , 2003, Cardiovascular research.

[730]  Palle Petersen,et al.  PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.

[731]  W. Kannel,et al.  Epidemiologic features of chronic atrial fibrillation: the Framingham study. , 1982, The New England journal of medicine.

[732]  Sander Verheule,et al.  Alterations in Atrial Electrophysiology and Tissue Structure in a Canine Model of Chronic Atrial Dilatation Due to Mitral Regurgitation , 2003, Circulation.

[733]  I. Khan,et al.  Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. , 2003, International journal of cardiology.

[734]  W. Stevenson,et al.  Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. , 1995, The American journal of cardiology.

[735]  J. Bourke,et al.  Paroxysmal Cycle Length Shortening in the Pulmonary Veins During Atrial Fibrillation Correlates with Arrhythmogenic Triggering Foci in Sinus Rhythm , 2002, Journal of cardiovascular electrophysiology.

[736]  E. Prystowsky,et al.  Sotalol: An important new antiarrhythmic. , 1999, American Heart Journal.

[737]  C. Gyldensted,et al.  Silent cerebral infarction in chronic atrial fibrillation. , 1987, Stroke.

[738]  J. Rothrock,et al.  Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study. , 1994, Archives of internal medicine.

[739]  J. Cohn,et al.  The Influence of Atrial Fibrillation on Prognosis in Mild to Moderate Heart Failure The V‐HeFT Studies , 1993, Circulation.

[740]  B. Olshansky,et al.  Thromboembolism in chronic atrial flutter: is the risk underestimated? , 1997, Journal of the American College of Cardiology.

[741]  J. Gore,et al.  Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective. , 2002, American heart journal.

[742]  S. Themistoclakis,et al.  Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents. , 2004, Journal of the American College of Cardiology.

[743]  A. Capucci,et al.  Dronedarone for prevention of atrial fibrillation: a dose-ranging study. , 2003, European heart journal.

[744]  S. Owada,et al.  [Long-term efficacy of combination therapy using antiarrhythmic agents and angiotensin converting enzyme inhibitor in patients with paroxysmal and persistent atrial fibrillation: importance of the timing of administration]. , 2003, Journal of cardiology.

[745]  C. Pandozi,et al.  N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. , 2005, Journal of the American College of Cardiology.

[746]  T. Binder,et al.  Diurnal variation of ventricular response to atrial fibrillation in patients with advanced heart failure. , 1995, American heart journal.

[747]  M. Allessie,et al.  Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.

[748]  James B Seward,et al.  Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. , 2002, Journal of the American College of Cardiology.

[749]  Patrick Gautier,et al.  Electrophysiologic Characterization of Dronedarone in Guinea Pig Ventricular Cells , 2003, Journal of cardiovascular pharmacology.

[750]  G. Kay,et al.  Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. , 2000, Circulation.

[751]  A. Torbicki,et al.  Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct‐current cardioversion , 1997, Clinical cardiology.

[752]  K. Matsuo,et al.  Extended Distribution of Prolonged and Fractionated Right Atrial Electrograms Predicts Development of Chronic Atrial Fibrillation in Patients with Idiopathic Paroxysmal Atrial Fibrillation , 2002 .

[753]  B. Gersh,et al.  Propafenone for paroxysmal atrial fibrillation. , 1988, The American journal of cardiology.

[754]  J. Halperin,et al.  Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. , 2001, The New England journal of medicine.

[755]  N. Ishikawa,et al.  Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation. , 2000, European heart journal.

[756]  E. Hylek,et al.  Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.

[757]  M. Brignole,et al.  Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. , 1998, Circulation.

[758]  Prashanthan Sanders,et al.  Electrical Remodeling of the Atria in Congestive Heart Failure: Electrophysiological and Electroanatomic Mapping in Humans , 2003, Circulation.

[759]  J. Porterfield,et al.  Therapeutic efficacy and safety of oral propafenone for atrial fibrillation. , 1989, The American journal of cardiology.

[760]  S. Lévy.  Factors Predisposing to the Development of Atrial Fibrillation , 1997, Pacing and clinical electrophysiology : PACE.

[761]  G. Lip,et al.  Coagulation activity is increased in the left atrium of patients with mitral stenosis. , 1995, Journal of the American College of Cardiology.

[762]  D. Leung,et al.  Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. , 1994, Journal of the American College of Cardiology.

[763]  A. Miller,et al.  Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. , 1990, American heart journal.

[764]  F. Marín,et al.  Effects of Pretreatment with Intravenous Flecainide on Efficacy of External Cardioversion of Persistent Atrial Fibrillation , 2004, Pacing and clinical electrophysiology : PACE.

[765]  E. Daoud,et al.  Left Ventricular‐Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study) , 2005, Journal of cardiovascular electrophysiology.

[766]  L. Thuesen,et al.  Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome , 1997, The Lancet.

[767]  H. Crijns,et al.  Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. , 1991, The American journal of cardiology.

[768]  W. Daniel,et al.  Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. , 1988, Journal of the American College of Cardiology.

[769]  A. Stead,et al.  Effects of age, race, sex, and smoking on prothrombin fragment 1.2 in a healthy population. , 1993, Clinical Chemistry.

[770]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[771]  L H Kuller,et al.  Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.

[772]  L. Jordaens,et al.  Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. , 1997, European heart journal.

[773]  A. Capucci,et al.  The role of oral 1C antiarrhythmic drugs in terminating atrial fibrillation. , 1999, Current opinion in cardiology.

[774]  W. Daniel,et al.  Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. , 1994, Journal of the American College of Cardiology.

[775]  B. Gersh,et al.  The natural history of lone atrial fibrillation. A population-based study over three decades. , 1987, The New England journal of medicine.

[776]  Gabriele Vicedomini,et al.  Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment. , 2004, Journal of the American College of Cardiology.

[777]  S. Hohnloser,et al.  Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. , 1995, Journal of the American College of Cardiology.

[778]  E. Prystowsky,et al.  Rate versus rhythm control in the management of patients with atrial fibrillation , 2005, Nature Clinical Practice Cardiovascular Medicine.

[779]  F. Morady,et al.  Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. , 1997, Circulation.

[780]  D. Wyse,et al.  Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial. , 2005, JAMA.

[781]  P. Vardas,et al.  Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study. , 2000, Chest.

[782]  L. Rydén,et al.  Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil. , 1990, Journal of the American College of Cardiology.

[783]  M. Santini,et al.  Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. , 1996, Journal of the American College of Cardiology.

[784]  A. Leaf,et al.  Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. , 2001, Journal of lipid research.

[785]  Ralph B D'Agostino,et al.  A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. , 2003, JAMA.

[786]  P. Genton,et al.  Effects of propranolol and of verapamil on heart rate and blood pressure in hyperthyroidism , 1984, Clinical pharmacology and therapeutics.

[787]  D. Scherf,et al.  Mechanism of flutter and fibrillation. , 1951, A.M.A. archives of internal medicine.

[788]  S. Nattel.  Rhythm versus rate control for atrial fibrillation management: what recent randomized clinical trials allow us to affirm. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[789]  B. Gersh,et al.  The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation. A double-blind study comparing quinidine, disopyramide and placebo. , 1984, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[790]  R. Harper,et al.  Determinants of increased regional left atrial coagulation activity in patients with mitral stenosis. , 1996, Circulation.

[791]  D. Singer,et al.  Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study , 2005, Circulation.

[792]  J. Brugada,et al.  Atrial fibrillation induced by atrioventricular nodal reentrant tachycardia. , 1997, The American journal of cardiology.

[793]  G. Lip,et al.  Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation , 2003, Circulation.

[794]  A. Capucci,et al.  Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. , 2000, European heart journal.

[795]  J Clémenty,et al.  Electrophysiological Breakthroughs From the Left Atrium to the Pulmonary Veins , 2000, Circulation.

[796]  S. Hohnloser,et al.  Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter. , 2004, Journal of the American College of Cardiology.

[797]  L. Goldman,et al.  Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. , 1998, Pacing and clinical electrophysiology : PACE.

[798]  E. Daoud,et al.  Effect of Verapamil on Immediate Recurrence of Atrial Fibrillation , 2000, Journal of cardiovascular electrophysiology.

[799]  K. Murray,et al.  Analysis of Cause-Specific Mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.

[800]  V. Boyko,et al.  Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. , 1998, Circulation.

[801]  L. Goldman,et al.  Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. , 1998, The New England journal of medicine.

[802]  李永军,et al.  Atrial Fibrillation , 1999 .

[803]  D. Fatkin,et al.  Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. , 1994, Circulation.

[804]  R. Grimm,et al.  Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. , 1993, Journal of the American College of Cardiology.

[805]  M. Allessie,et al.  High-density mapping of electrically induced atrial fibrillation in humans. , 1994, Circulation.

[806]  P. Vardas,et al.  Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study , 2000, Heart.

[807]  G A Ewy,et al.  Myocardial Necrosis from Direct Current Countershock: Effect of Paddle Electrode Size and Time Interval Between Discharges , 1974, Circulation.

[808]  I. Khan.  Atrial stunning: determinants and cellular mechanisms. , 2003, American heart journal.

[809]  H. Matsuoka,et al.  Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy. , 1995, Japanese circulation journal.

[810]  P. Kowey,et al.  Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting. , 2004, The American journal of cardiology.

[811]  G. Guyatt,et al.  Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis. , 2003, Archives of internal medicine.

[812]  D P Zipes,et al.  Radiofrequency catheter ablation of the atria reduces inducibility and duration of atrial fibrillation in dogs. , 1995, Circulation.

[813]  G. Lip.  Hypercoagulability and haemodynamic abnormalities in atrial fibrillation , 2022 .

[814]  R. Kronmal,et al.  Stroke risk in an elderly population with atrial fibrillation , 1999, Journal of General Internal Medicine.

[815]  R. Kerber,et al.  Ischemic cerebrovascular complications and risk factors in idiopathic hypertrophic subaortic stenosis. , 1991, Stroke.

[816]  J. Rees,et al.  Improved control of atrial fibrillation with combined pindolol and digoxin therapy. , 1989, European heart journal.

[817]  A. Efthymiadis,et al.  Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias. , 1995, Acta cardiologica.

[818]  A. De Simone,et al.  Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. , 2005, Journal of the American College of Cardiology.

[819]  I. V. Van Gelder,et al.  Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation , 1999, Heart.

[820]  A. Ducharme,et al.  Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials , 2003, Circulation.

[821]  A. Toft,et al.  Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation. , 1979, The American journal of cardiology.

[822]  S. Hohnloser,et al.  Atrial Fibrillation and Congestive Heart Failure: Specific Considerations at the Intersection of Two Common and Important Cardiac Disease Sets , 2002, Journal of cardiovascular electrophysiology.

[823]  SamuelLévy,et al.  Characterization of Different Subsets of Atrial Fibrillation in General Practice in France , 1999 .

[824]  S. Amitani,et al.  Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[825]  R. Cheung.  Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. , 1998, JAMA.

[826]  E. Aliot,et al.  The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. , 1988, Progress in cardiovascular diseases.

[827]  E. Picano,et al.  Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult patients with hypertrophic cardiomyopathy. Echo Persantine Italian Cooperative (EPIC) Study Group, Subproject Hypertrophic Cardiomyopathy. , 1997, Circulation.

[828]  J. Alpert,et al.  Amiodarone for refractory atrial fibrillation. , 1986, The American journal of cardiology.

[829]  A. Kamkin,et al.  Mechanically induced potentials in atrial fibroblasts from rat hearts are sensitive to hypoxia/reoxygenation , 2003, Pflügers Archiv.

[830]  R. Hart,et al.  Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention , 1999, Annals of Internal Medicine.

[831]  Ying Wang,et al.  KCNQ1 gain-of-function mutation in familial atrial fibrillation. , 2003, Science.

[832]  G. Klein,et al.  Risk of Sudden Arrhythmic Death in the Wolff‐Parkinson‐White Syndrome: Current Perspectives , 1994, Pacing and clinical electrophysiology : PACE.

[833]  G. Lip,et al.  Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. , 1996, American heart journal.

[834]  D. Armstrong,et al.  Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation , 1999, BMJ.

[835]  G. Opolski,et al.  Atrial natriuretic peptide level after cardioversion of chronic atrial fibrillation. , 2002, International journal of cardiology.

[836]  R. Califf,et al.  Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. , 1997, Journal of the American College of Cardiology.

[837]  I. V. Van Gelder,et al.  Effects of flecainide on the atrial defibrillation threshold. , 1989, The American journal of cardiology.

[838]  J. Pantridge,et al.  The effects of shock energy, propranolol, and verapamil on cardiac damage caused by transthoracic countershock. , 1984, Circulation.

[839]  G. Jensen,et al.  Rising Rates of Hospital Admissions for Atrial Fibrillation , 2003, Epidemiology.

[840]  S. Connolly,et al.  Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. , 1999, Circulation.

[841]  J. Bogousslavsky,et al.  Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation , 1990, Neurology.

[842]  G. Kay,et al.  Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial. DAPPAF Phase 1 Investigators. , 1998, Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing.

[843]  D. Haines,et al.  Electrical, Morphological, and Ultrastructural Remodeling and Reverse Remodeling in a Canine Model of Chronic Atrial Fibrillation , 2000, Circulation.

[844]  J. Halperin.  Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation. , 2005, Journal of the American College of Cardiology.

[845]  F. Morady,et al.  Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. , 1999, The New England journal of medicine.

[846]  L. Rydén,et al.  Long-term efficacy of flecainide in paroxysmal atrial fibrillation. , 2009, Acta medica Scandinavica.

[847]  L. Geddes,et al.  Electrocardiographic and serum enzymic alterations associated with cardiac alterations induced in dogs by single transthoracic damped sinusoidal defibrillator shocks of various strengths. , 1979, American heart journal.

[848]  M. Ovadia,et al.  Human experience with amiodarone in the embryonic period. , 1994, The American journal of cardiology.

[849]  J. Landry,et al.  Factors predisposing to supraventricular tachyarrhythmias after coronary artery bypass grafting. , 1986, The American journal of cardiology.

[850]  James B Seward,et al.  The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. , 2003, Journal of the American College of Cardiology.

[851]  A. Sheikhzadeh,et al.  Relation of left atrial appendage function to the duration and reversibility of nonvalvular atrial fibrillation. , 1995, The American journal of cardiology.

[852]  P C Deedwania,et al.  Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. , 1998, Circulation.

[853]  G A Ewy,et al.  Effects of electrical countershock on serum creatine phosphokinase (CPK) isoenzyme activity. , 1976, The American journal of cardiology.

[854]  U Schotten,et al.  “Early” Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat , 2004, Circulation.

[855]  SergioCoccheri,et al.  Indobufen Versus Warfarin in the Secondary Prevention of Major Vascular Events in Nonrheumatic Atrial Fibrillation , 1997 .

[856]  C. Foster,et al.  Amiodarone in pregnancy. Case report and review of the literature. , 1988, International journal of cardiology.

[857]  S Nattel,et al.  Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. , 1997, Circulation research.

[858]  R. Peters,et al.  High dose oral amiodarone loading exerts important hemodynamic actions in patients with congestive heart failure. , 1994, Journal of the American College of Cardiology.

[859]  J. Davignon.  Beneficial Cardiovascular Pleiotropic Effects of Statins , 2004, Circulation.

[860]  G. Ferrari,et al.  Regular Ventricular Rhythms Before Conversion of Recent Onset Atrial Fibrillation to Sinus Rhythm , 1994, Pacing and clinical electrophysiology : PACE.

[861]  M. Noble,et al.  Myocardial contractility is not constant during spontaneous atrial fibrillation in patients. , 1998, Circulation.

[862]  Efficacy of Biphasic Shock for Transthoracic Cardioversion of Persistent Atrial Fibrillation: , 2004 .

[863]  Rose Anne Kenny,et al.  Prevalence of atrial fibrillation and eligibility for anticoagulants in the community , 1998, The Lancet.

[864]  G. Lip,et al.  Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. , 1996, Circulation.

[865]  A. Louhija,et al.  Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion , 1974, Clinical pharmacology and therapeutics.

[866]  G. Ertl,et al.  Alpha-receptor restriction of coronary blood flow during atrial fibrillation. , 1983, The American journal of cardiology.

[867]  G. Fontana,et al.  Amiodarone versus quinidine for conversion of recent onset atrial fibrillation to sinus rhythm , 1991 .